ATE311228T1 - Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel - Google Patents

Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel

Info

Publication number
ATE311228T1
ATE311228T1 AT01307370T AT01307370T ATE311228T1 AT E311228 T1 ATE311228 T1 AT E311228T1 AT 01307370 T AT01307370 T AT 01307370T AT 01307370 T AT01307370 T AT 01307370T AT E311228 T1 ATE311228 T1 AT E311228T1
Authority
AT
Austria
Prior art keywords
dmxaa
docetaxel
combinations
paclitaxel
anticancer combinations
Prior art date
Application number
AT01307370T
Other languages
English (en)
Inventor
William Robert Wilson
Original Assignee
Cancer Rec Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Rec Tech Ltd filed Critical Cancer Rec Tech Ltd
Application granted granted Critical
Publication of ATE311228T1 publication Critical patent/ATE311228T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01307370T 2001-08-30 2001-08-30 Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel ATE311228T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01307370A EP1287854B1 (de) 2001-08-30 2001-08-30 Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel

Publications (1)

Publication Number Publication Date
ATE311228T1 true ATE311228T1 (de) 2005-12-15

Family

ID=8182225

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01307370T ATE311228T1 (de) 2001-08-30 2001-08-30 Antikrebs-kombinationen aus dmxaa und paclitaxel oder docetaxel

Country Status (6)

Country Link
EP (1) EP1287854B1 (de)
AT (1) ATE311228T1 (de)
DE (1) DE60115429T2 (de)
DK (1) DK1287854T3 (de)
ES (1) ES2252160T3 (de)
SI (1) SI1287854T1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101896177A (zh) * 2007-12-13 2010-11-24 诺瓦提斯公司 用于治疗癌症的治疗剂的组合

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
JP2001247459A (ja) * 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法

Also Published As

Publication number Publication date
DK1287854T3 (da) 2006-04-03
SI1287854T1 (sl) 2006-08-31
EP1287854B1 (de) 2005-11-30
DE60115429T2 (de) 2006-08-10
DE60115429D1 (de) 2006-01-05
EP1287854A1 (de) 2003-03-05
ES2252160T3 (es) 2006-05-16

Similar Documents

Publication Publication Date Title
ATE415963T1 (de) Zusammensetzungen aus dmxaa und anderen antikrebsmittel
MA29946B1 (fr) Nouvelles compositions ameliorees pour la therapie du cancer
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
ATE342054T1 (de) Verfahren und zusammansetzung zur behandlung von krebs
BRPI0607017B8 (pt) composição farmacêutica compreendendo memantina e donezepil, e seu uso para o tratamento de condições relacionadas ao snc
ATE474568T1 (de) Synergistische kombination von (-) -gossypol mit docetaxel oder paclitaxel zur behandlung von krebs.
FI952248A7 (fi) Kasvainvastaisia koostumuksia, jotka sisältävät taksaanijohdannaisia
ATE420117T1 (de) Kovalent an hyaluronsäure oder dessen derivate gebundene taxane
ATE196844T1 (de) Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
EP1392328A4 (de) Krebstherapie
DE60109632D1 (de) Katechin und quercetin zur pharmazeutischen oder diätetischen verwendung
ATE410203T1 (de) Lipase-hemmende zusammensetzung
ATE175343T1 (de) Kosmetisches und/oder nahrungsmittel enthaltend eine nicht-verseifbare fraktion von sesamöl und vitamin-e
ATE554753T1 (de) 2,2'-dithio-bis(ethansulfonat) für den einsatz zur hemmung paclitaxel-induzierter abnormer thermoesthesia
ATE241376T1 (de) Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
DE60115429D1 (de) Antikrebs-Kombinationen aus DMXAA und Paclitaxel oder Docetaxel
ATE541577T1 (de) Metallo-fullerenole und ihre anwendung bei der herstellung von medikamenten zur hemmung des tumorwachstums
PT1259502E (pt) Analogos biologicamente activos da discodermolida
ATE298328T1 (de) Taxan-derivate für die behandlung von krebs
CA2325041A1 (en) Ultra-vit. plus
BR0211762A (pt) Certos policetìdeos substituìdos, composições farmacêuticas contendo os mesmos e seu uso no tratamento de tumores
ATE273293T1 (de) Aminoalkenylbenzoyl-benzofurane oder benzothiophene, verfahren zur ihrer herstellung und sie enthaltende zubereitungen
ATE306927T1 (de) Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
FI20010097A7 (fi) Askorbaattia ja lysiiniä synergistisiä koostumuksia niitä tiloja varten, jotka liittyvät soluvälineen degeneraatioon

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1287854

Country of ref document: EP